240 related articles for article (PubMed ID: 2343147)
21. Cytodiagnosis of extramedullary plasmacytomas.
Goel G; Rai S; Naik R; Gupta A; Baliga P; Sinha R
Acta Cytol; 2010; 54(3):255-8. PubMed ID: 20518407
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience.
Alghisi A; Borghetti P; Maddalo M; Roccaro AM; Tucci A; Mazzola R; Magrini SM; Lo Casto A; Bonù ML; Tomasini D; Pasinetti N; Peretto G; Bertagna F; Tomasi C; Buglione M; Triggiani L
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1773-1779. PubMed ID: 33201300
[TBL] [Abstract][Full Text] [Related]
24. Solitary plasmacytoma.
Kayrouz T; Jose B; Chu AM; Scott RM
J Surg Oncol; 1983 Sep; 24(1):46-8. PubMed ID: 6887936
[TBL] [Abstract][Full Text] [Related]
25. Solitary plasmacytoma of bone: fourteen years disease-free survival.
Basu S; Kaur P; Singh S
J Assoc Physicians India; 2004 Feb; 52():161-2. PubMed ID: 15656055
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
[TBL] [Abstract][Full Text] [Related]
27. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
29. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
Knobel D; Zouhair A; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Oner FD; Landmann C; Castelain B; Ozsahin M;
BMC Cancer; 2006 May; 6():118. PubMed ID: 16677383
[TBL] [Abstract][Full Text] [Related]
31. Metastatic extramedullary plasmacytoma of the lung.
Wang J; Pandha HS; Treleaven J; Powles R
Leuk Lymphoma; 1999 Oct; 35(3-4):423-5. PubMed ID: 10706469
[TBL] [Abstract][Full Text] [Related]
32. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
Kilciksiz S; Karakoyun-Celik O; Agaoglu FY; Haydaroglu A
ScientificWorldJournal; 2012; 2012():895765. PubMed ID: 22654647
[TBL] [Abstract][Full Text] [Related]
33. Solitary bone plasmacytoma: management of isolated local relapse following radiotherapy.
Lewanski CR; Bates T; Bowen J; Ashford RF
Clin Oncol (R Coll Radiol); 1999; 11(5):348-51. PubMed ID: 10591824
[TBL] [Abstract][Full Text] [Related]
34. Extramedullary plasmacytomas and solitary plasma cell tumours of bone.
Brinch L; Hannisdal E; Abrahamsen AF; Kvaløy S; Langholm R
Eur J Haematol; 1990 Feb; 44(2):132-5. PubMed ID: 2318296
[TBL] [Abstract][Full Text] [Related]
35. Extramedullary facial plasmacytomas with anaplastic features: a diagnostic dilemma with implications for treatment.
Aboulafia DM; Lee RM; Hafermann M; Chu FW; Fenske M
Am J Clin Oncol; 1998 Aug; 21(4):401-5. PubMed ID: 9708642
[TBL] [Abstract][Full Text] [Related]
36. Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma.
Skóra T; Pudełek K; Nowak-Sadzikowska J; Pietrasz M; Szyszka-Charewicz B; Jakubowicz J
Hematol Oncol; 2017 Sep; 35(3):317-322. PubMed ID: 26450521
[TBL] [Abstract][Full Text] [Related]
37. Solitary plasmacytoma of bone and soft tissue.
Bolek TW; Marcus RB; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
[TBL] [Abstract][Full Text] [Related]
38. Solitary bone and extramedullary plasmacytoma.
Weber DM
Hematology Am Soc Hematol Educ Program; 2005; ():373-6. PubMed ID: 16304406
[TBL] [Abstract][Full Text] [Related]
39. Solitary phalanx plasmacytoma relapse with disseminated extramedullary plasmacytomas and myeloma after short duration of remission.
Celik I; Baltali E; Barişta I; Tekuzman G; Kansu E; Atahan L; Güngen Y; Firat D
Anticancer Res; 1996; 16(2):959-62. PubMed ID: 8687159
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy of solitary plasmacytoma.
Krause S; Hillengass J; Goldschmidt H; Debus J; Neuhof D
Ann Hematol; 2011 Sep; 90(9):1093-7. PubMed ID: 21336625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
